TY  - JOUR
PY  - 2019//
TI  - Evaluation of bronchoalveolar lavage fluid from patients in an outbreak of e-cigarette, or vaping, product use-associated lung injury - 10 states, August-October 2019
JO  - MMWR: Morbidity and mortality weekly report
A1  - Blount, Benjamin C.
A1  - Karwowski, Mateusz P.
A1  - Morel-Espinosa, Maria
A1  - Rees, Jon
A1  - Sosnoff, Connie
A1  - Cowan, Elizabeth
A1  - Gardner, Michael
A1  - Wang, Lanqing
A1  - Valentin-Blasini, Liza
A1  - Silva, Lalith
A1  - De Jesús, Víctor R.
A1  - Kuklenyik, Zsuzsanna
A1  - Watson, Cliff
A1  - Seyler, Tiffany
A1  - Xia, Baoyun
A1  - Chambers, David
A1  - Briss, Peter
A1  - King, Brian A.
A1  - Delaney, Lisa
A1  - Jones, Christopher M.
A1  - Baldwin, Grant T.
A1  - Barr, John R.
A1  - Thomas, Jerry
A1  - Pirkle, James L.
SP  - 1040
EP  - 1041
VL  - 68
IS  - 45
N2  - CDC, the Food and Drug Administration (FDA), state and local health departments, and multiple public health and clinical partners are investigating a national outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI). Based on data collected as of October 15, 2019, 86% of 867 EVALI patients reported using tetrahydrocannabinol (THC)-containing products in the 3 months preceding symptom onset (1). Analyses of THC-containing product samples by FDA and state public health laboratories have identified potentially harmful constituents in these products, such as vitamin E acetate, medium chain triglyceride oil (MCT oil), and other lipids (2,3) (personal communication, D.T. Heitkemper, FDA Forensic Chemistry Center, November 2019). Vitamin E acetate, in particular, might be used as an additive in the production of e-cigarette, or vaping, products; it also can be used as a thickening agent in THC products (4). Inhalation of vitamin E acetate might impair lung function (5-7).<p />  <p>Language: en</p>
LA  - en
SN  - 0149-2195
UR  - http://dx.doi.org/10.15585/mmwr.mm6845e2
ID  - ref1
ER  -